In 2026 and 2026, I have seen more “goodbye” posts on LinkedIn or other platforms than ever before. Especially from former colleagues over 50.
Pharma has always been demanding. But the last 2 years are feeling different.
Not because leaders suddenly became less capable or less needed, but because the system itself is under sustained pressure.
AI is accelerating R&D and decision cycles. Pipelines are under productivity strain. Patent cliffs and pricing reforms are squeezing margins. Cost reductions, ongoing reorganizations and workforce adjustments are no longer exceptions.
They are structural.
In the middle of all that, leaders are expected to stay focused, decisive, empathetic and resilient.
I know this environment well.
I spent more than 26 years in Global Pharma, Strategic Marketing. Leading international teams, delivering launches, navigating reorganizations, rolling out yet another “new” change model. Managing with fewer resources while expectations kept rising.
I’ve also been on the other side of the table. Laid off. From one day to the next.
Change is constant. Capacity is not.
Most leadership systems were designed for stability with occasional disruption. That world no longer exists.
In a recent podcast conversation with a senior executive recruiter, one thing became very clear: change is no longer an event to manage for a period of time. It has become the operating context.
Roles shift faster. Skills expire sooner. Leaders are recruited for their ability to navigate continuous change.
Today, it’s less about what you know and more about how quickly you can adapt. Organizations are hiring for your ability to navigate constant change, not just your past achievements.
Yet many organizations, and their leadership models, still treat change as temporary. Something to “get through” before things settle again.
They don’t.
The silent erosion of leadership capacity
What I increasingly see is not a lack of competence or commitment but a gradual erosion of leadership capacity.
Performance still looks fine on paper. While leadership capacity is quietly eroding underneath. Decisions still get made. Targets are still met.
But clarity drops. Decision-making takes longer. Complex issues feel heavier.
Not because leaders are failing but because sustained pressure has been normalized.
This is the most expensive phase in leadership: when things still work, while capacity and performance quietly declines underneath.
Volatility is the baseline
There is no slowdown ahead.
An industry survey shows that 66% of leaders expect even more change, confirming that volatility is now the default operating condition.
This has profound implications. Leaders can no longer treat change as episodic. They must treat it as structural.
What I often see instead is delay. Things get dragged on, until something happens:
- a critical health signal,
- a moment where focus is gone,
- an important decision that suddenly feels overwhelming.
By then, your system has been running on adrenaline for far too long.
Burnout is structural, not personal
Many organizations state that leadership development, resilience, change and adaptability are priorities. In practice, they often become checkboxes. KPIs on a scorecard.
Wellbeing programs exist. But the real budget goes to AI and optimization. Stress levels keep rising. Burnout is increasing. Working more intense, with less colleagues around. It looks different today. It’s not just long hours. It’s cognitive overload: constant context switching, rapid tech change, unclear direction and sustained uncertainty.
Mental fatigue has become one of the leading burnout drivers.
Why resilience is misunderstood
This is often labelled resilience. In reality, it’s endurance: pushing through, adapting endlessly, not dropping the ball. Endurance is not the same as adaptation.
True resilience is the ability to recover clarity fast enough to make good decisions again, especially in environments that never slow down.
Yet in recruitment and leadership language, resilience often still means: keep going, don’t quit, survive the next change or round of layoffs.
What’s missing is investment in:
- recovery
- nervous system regulation
- sustained decision clarity
Recent research shows that the leadership behaviors that build organizational resilience are those enabling early detection, adaptive response and recovery learning, not prolonged endurance.
Pharma specific pressures shaping 2026
These leadership demands are amplified by industry dynamics.
AI and R&D transformation AI has moved from pilots into core R&D processes. Emerging data suggests AI could reduce preclinical timelines by up to 40% and cut costs by around 30%. Yet only a minority of companies have scaled AI enterprise wide. This is not just a technology challenge. It’s a leadership and systems challenge.
Structural pressure beyond R&D Persistent layoffs, pipeline pressure, patent expiries and regulatory shifts are forcing new business models. Smaller, more agile players are gaining ground, while large organizations struggle with speed and internal complexity.
Leadership agility, not just technical strategy, is becoming a competitive differentiator.
A final reflection
If the system no longer slows down, leadership cannot rely on endurance alone. Leadership is no longer about pushing harder. It’s about staying clear and focused when the system itself is under pressure.
When the company isn’t taking your health, resilience and clarity seriously, it doesn’t mean you need to follow the same path.